NCT06079671 2026-04-02
eVOLVECervical
AstraZeneca
Phase 3 Recruiting
Clinical Trials
7 trialsNCT02641639 2025-03-24
FOCUS: PCC + Bevacizumab + CA4P Versus PCC + Bevacizumab + Placebo for Subjects With Platinum Resistant Ovarian Cancer
Mateon Therapeutics
Phase 2/3 Terminated
NCT04201561 2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3 Unknown
NCT00740116 2022-03-15
Tranexamic Acid in Surgery of Advanced Ovarian Cancer
University Hospital, Linkoeping
Phase 4 Completed
NCT04237090 2020-10-12
PREMED-F1
Ciusss de L'Est de l'Île de Montréal
Phase 3 Completed
NCT01144442 2019-07-30
WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer
Masonic Cancer Center, University of Minnesota
Phase NA Terminated
NCT00278434 2017-11-24
Zoledronate in Treating Patients With Cervical Intraepithelial Neoplasia 2/3 or 3
University of California, San Francisco
Phase 1 Terminated